Skip to content
Beacon

ELILDirexion Daily LLY Bull 2X Shares

Take a bet1y track recordRanked #461 of 775 in this goal

Seeks daily investment results of 200% of the daily performance of LLY.

By Direxion Funds · Launched 2025

Annual Cost

1.07%

#5,126 of 5,562 · expensive

Fund Size

$23M

#4,266 of 5,562 · small

Return (1Y)Goal

+52.8%

Track Record

1 year

#4,273 of 5,562 · young

Performance

Total-return NAV · USD
Growth of $10,000
$15,598+56.0%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Equity

Region

North america

Strategy

Leveraged

Sector

Health care

Focus

Single Stock

What it actually holds

By weight

Concentration

Top 9 holdings = 137.4% of fundconcentrated

DREYFUS
31.2%
GOLDMAN SACHS LIQ ES FD A
22.1%
N/A
19.8%
N/A
19.6%
DREYFUS GOVERNMENT CASH MANAGE
18.3%
Eli Lilly & Co.
17.6%
GOLDMAN FINANCIAL
6.7%
N/A
1.2%
N/A
0.8%

Asset allocation

Cash
60.2%
Stocks
39.8%

By sector

Healthcare
100.0%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
75.3%High

Year-on-year price swings

Max drawdown
-56.0%Severe

Worst peak-to-trough loss

Sharpe (3Y)
Unavailable

Needs 3+ years of history

Sortino (3Y)
Not yet

Needs 3+ years of history

Where to buy

Listing

Exchange
NASDAQ Global Select Market

Full fund details

Objective
Seeks daily investment results of 200% of the daily performance of LLY.
Strategy
Invests primarily in securities of LLY and financial instruments like swap agreements to achieve 2X daily leveraged exposure. The Fund rebalances daily to maintain this leverage, focusing on the healthcare sector and pharmaceutical industry.
Inception date
March 25, 2025
Fund family
Direxion Funds

Our take

Structural notes on how this fund behaves. Read our guide on the 6 warning signs.

Leveraged single stock
Critical

Leveraged single-stock ETF — documented structural drag

Single-stock leveraged ETFs magnify one stock's daily move. Research on these products (Bessembinder et al., 2024) finds 56% posted negative absolute returns over one year, with ~9.5% annual drag versus the underlying stock. Daily rebalancing plus financing costs work against the investor on any holding period longer than a few days.

Source: Bessembinder, Cooper, Zhang — 'Leveraged Single-Stock ETFs' (SSRN 2024)

Why we flagged this: strategy=leveraged + single_stock_wrapper

Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More

What's next?

You've reviewed ELIL. Save it to your watchlist to track it alongside the other funds you're weighing.

Data updated on 2026-06-19